Thomas B. Karasic

Futibatinib for <i>FGFR2</i> -Rearranged Intrahepatic Cholangiocarcinoma

Lipika Goyal, Funda Meric‐Bernstam, Antoine Hollebecque et al. · New England Journal of Medicine · 2023 · 541 citations · Full text

Medicine, Oncology, Pharmacology +16

Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer

Thomas B. Karasic, Mark H. O’Hara, Arturo Loaiza‐Bonilla et al. · JAMA Oncology · 2019 · 290 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in <i>BRCA1</i>, <i>BRCA2</i>, or <i>PALB2</i>

Kim A. Reiss, Rosemarie Mick, Mark H. O’Hara et al. · Journal of Clinical Oncology · 2021 · 239 citations

Medicine, Oncology, Pharmacology +14

Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma

Mark Yarchoan, Parul Agarwal, Augusto Villanueva et al. · Cancer Research · 2019 · 158 citations · Full text

Medicine, Oncology, Pharmacology +17

Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial

Kim A. Reiss, Rosemarie Mick, Ursina Teitelbaum et al. · The Lancet Oncology · 2022 · 139 citations · Full text

Medicine, Oncology, Pharmacology +9